My mother suffered from early-onset Alzheimer’s and so I have considered—albeit briefly—to take a predictive test for such an illness. But I wound up deciding against, mostly because I didn’t want the knowledge to alter my life.
But most people are not like me, according to a new survey out of the Tufts Medical Center. Apparently 76 percent of the 1,463 respondents would take a hypothetical test for Alzheimer’s, breast or prostate cancer, or arthritis. And they are willing to pay for it. Up to $600.
To read the full, original article click on this link: The Popularity of Predictive Medical Testing: Scientific American Podcast
